Neil Thompson
Sales & Marketing chez POLYPEPTIDE GROUP AG
Fortune : 41 539 $ au 31/05/2024
Profil
Mr. Neil J.
Thompson is a Director-Global Sales & Marketing at PolyPeptide Group AG.
Mr. Thompson was previously employed as a Product Manager-Peptide by Bachem (U.K.) Ltd., a Product Manager by Bachem AG, and an Assistant Manager-Production by Peninsula Laboratories Europe Ltd.
He received his undergraduate degree from Liverpool John Moores University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
POLYPEPTIDE GROUP AG
0,00% | 31/12/2023 | 1 122 ( 0,00% ) | 41 539 $ | 31/05/2024 |
Postes actifs de Neil Thompson
| Sociétés | Poste | Début |
|---|---|---|
| POLYPEPTIDE GROUP AG | Sales & Marketing | 01/01/2022 |
Anciens postes connus de Neil Thompson
| Sociétés | Poste | Fin |
|---|---|---|
Bachem AG
 Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Corporate Officer/Principal | 01/01/2003 |
Bachem (U.K.) Ltd.
 Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Corporate Officer/Principal | 01/01/2003 |
Formation de Neil Thompson
| Liverpool John Moores University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| POLYPEPTIDE GROUP AG | Health Technology |
| Entreprise privées | 2 |
|---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
Bachem (U.K.) Ltd.
Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Health Technology |
